Literature DB >> 16469747

Estrogen receptor-alpha binds p53 tumor suppressor protein directly and represses its function.

Wensheng Liu1, Santhi D Konduri, Sanjay Bansal, Bijaya K Nayak, Sigrid A Rajasekaran, Sankunny M Karuppayil, Ayyappan K Rajasekaran, Gokul M Das.   

Abstract

Estrogen receptor-alpha (ERalpha) promotes proliferation of breast cancer cells, whereas tumor suppressor protein p53 impedes proliferation of cells with genomic damage. Whether there is a direct link between these two antagonistic pathways has remained unclear. Here we report that ERalpha binds directly to p53 and represses its function. The activation function-2 (AF-2) domain of ERalpha and the C-terminal regulatory domain of p53 are necessary for the interaction. Knocking down p53 and ERalpha by small interfering RNA elicits opposite effects on p53-target gene expression and cell cycle progression. Remarkably, ionizing radiation that causes genomic damage disrupts the interaction between ERalpha and p53. Ionizing radiation together with ERalpha knock down results in additive effect on transcription of endogenous p53-target gene p21 (CDKN1) in human breast cancer cells. Our findings reveal a novel mechanism for regulating p53 and suggest that suppressing p53 function is an important component in the pro-proliferative role of ERalpha.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16469747     DOI: 10.1074/jbc.C600001200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  81 in total

1.  Glucocorticoid receptor activation inhibits p53-induced apoptosis of MCF10Amyc cells via induction of protein kinase Cε.

Authors:  Moammir H Aziz; Hong Shen; Carl G Maki
Journal:  J Biol Chem       Date:  2012-07-06       Impact factor: 5.157

2.  Effects of the environmental mammary carcinogen 6-nitrochrysene on p53 and p21(Cip1) protein expression and cell cycle regulation in MCF-7 and MCF-10A cells.

Authors:  Yuan-Wan Sun; Christopher R Herzog; Jacek Krzeminski; Shantu Amin; Gary Perdew; Karam El-Bayoumy
Journal:  Chem Biol Interact       Date:  2007-06-28       Impact factor: 5.192

Review 3.  Pathophysiology of Aortic Valve Stenosis: Is It Both Fibrocalcific and Sex Specific?

Authors:  Yoginee Sritharen; Maurice Enriquez-Sarano; Hartzell V Schaff; Grace Casaclang-Verzosa; Jordan D Miller
Journal:  Physiology (Bethesda)       Date:  2017-05

Review 4.  Tumor suppressor p53 and estrogen receptors in nuclear-mitochondrial communication.

Authors:  Nadi T Wickramasekera; Gokul M Das
Journal:  Mitochondrion       Date:  2013-10-29       Impact factor: 4.160

5.  Levetiracetam enhances p53-mediated MGMT inhibition and sensitizes glioblastoma cells to temozolomide.

Authors:  George C Bobustuc; Cheryl H Baker; Arati Limaye; Wayne D Jenkins; Gary Pearl; Nicholas G Avgeropoulos; Santhi D Konduri
Journal:  Neuro Oncol       Date:  2010-06-04       Impact factor: 12.300

Review 6.  TP53 Mutations and Outcomes in Breast Cancer: Reading beyond the Headlines.

Authors:  Ashkan Shahbandi; Hoang D Nguyen; James G Jackson
Journal:  Trends Cancer       Date:  2020-02-05

Review 7.  The expanding universe of p53 targets.

Authors:  Daniel Menendez; Alberto Inga; Michael A Resnick
Journal:  Nat Rev Cancer       Date:  2009-10       Impact factor: 60.716

8.  Estrogen receptor acting in cis enhances WT and mutant p53 transactivation at canonical and noncanonical p53 target sequences.

Authors:  Daniel Menendez; Alberto Inga; Michael A Resnick
Journal:  Proc Natl Acad Sci U S A       Date:  2010-01-04       Impact factor: 11.205

9.  Potential interference of aluminum chlorohydrate with estrogen receptor signaling in breast cancer cells.

Authors:  Vyron A Gorgogietas; Ioannis Tsialtas; Natalie Sotiriou; Vasiliki C Laschou; Aikaterini G Karra; Demetres D Leonidas; George P Chrousos; Evagelia Protopapa; Anna-Maria G Psarra
Journal:  J Mol Biochem       Date:  2018

10.  Potential risk factors for cutaneous squamous cell carcinoma include oral contraceptives: results of a nested case-control study.

Authors:  Maryam M Asgari; Jimmy T Efird; E Margaret Warton; Gary D Friedman
Journal:  Int J Environ Res Public Health       Date:  2010-02-03       Impact factor: 3.390

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.